Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial

作者：Mahrukh M. Syeda, Georgina V Long, James H. Garrett, Victoria Atkinson, Mario Santinami, Dirk Schadendorf, A. Hauschild, Michael Millward, Mario Mandalà, Vanna Chiarion‐Sileni, Michael Smylie, G. M. Manikhas, Dummer Reinhard, Jennifer Wiggins, Saim Ali, Sachin Bajirao Adnaik, Monique Tan, Maya Dajee, David Polsky · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00139-1 · 被引用次数：28 · 研究领域：Cancer Genomics and Diagnostics、Cutaneous Melanoma Detection and Management、Cancer Cells and Metastasis